Specialised Commissioning continues to be an issue of significance and uncertainty for both industry and the NHS. What do the latest reports of regional push back on the plans for devolution to ICBs mean?
Ahead of our NHS Transformation Symposium, former Pharma UK Market Access Director, Richard Marsh offers his thoughts on transforming the NHS.
As our developers experiment with integrating AI into our tools, we demonstrate the potential (and current limitations) of this technology with ChatGPT
Today the UK Department of Health and Social Care launched a new strategy to boost NHS access to innovative medical technology. Prof Phil Richardson shares his thoughts and reflections on the new policy.